According to Arrowhead Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 06:02 PM, company Senior Vice President, Hamilton James C disclosed selling 19,375 shares at a cost of $72.48. At the time of this transaction (Jan 06), this trade was worth $1,404,276 in […]
According to Kvh Industries Inc \De\’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 04:10 PM, company CTO, Balog Robert J disclosed selling 3,159 shares at a cost of $11.98. At the time of this transaction (Jan 05), this trade was worth $37,845 in total. […]
According to Arrowhead Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 06:02 PM, company Senior Vice President, Hamilton James C disclosed selling 19,375 shares at a cost of $72.53. At the time of this transaction (Jan 05), this trade was worth $1,405,303 in […]
According to Toro Co’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 04:08 PM, company Director, Cooper Janet Katherine disclosed selling 4,561 shares at a cost of $97.32. At the time of this transaction (Jan 06), this trade was worth $443,894 in total. As of […]
According to Flexion Therapeutics Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 06:02 PM, company Chief Business Officer, Muzikant Adam disclosed selling 4,005 shares at a cost of $11.13. At the time of this transaction (Jan 05), this trade was worth $44,576 in total. […]
According to Tyme Technologies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 04:05 PM, company Chief Science Officer, Hoffman Steve disclosed selling 56,250 shares at a cost of $1.41. At the time of this transaction (Jan 06), this trade was worth $79,313 in total. […]
According to Flexion Therapeutics Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 05:58 PM, company Chief Medical Officer, Kelley Scott disclosed selling 6,829 shares at a cost of $11.13. At the time of this transaction (Jan 05), this trade was worth $76,007 in total. […]
According to Tyme Technologies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 04:05 PM, company Chief Science Officer, Hoffman Steve disclosed selling 56,250 shares at a cost of $1.36. At the time of this transaction (Jan 05), this trade was worth $76,500 in total. […]
According to Flexion Therapeutics Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 05:56 PM, company Chief Regulatory Officer, Wentworth Kerry disclosed selling 6,829 shares at a cost of $11.13. At the time of this transaction (Jan 05), this trade was worth $76,007 in total. […]
According to Homology Medicines, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 07 04:05 PM, company Chief Scientific Officer, Seymour Albert disclosed selling 10,000 shares at a cost of $11.44. At the time of this transaction (Jan 05), this trade was worth $114,422 in total. […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
